Alliance Clinical Network (ACN) is dedicated to advancing breakthrough medical treatments for all with their fully integrated, wholly owned, and operated clinical research sites. With a diverse participant pool of over 250,000, ACN has been instrumental in delivering exceptional clinical trial data over the last decade. The company offers three key advantages to sponsors and partner CROs: expedited study startup and rapid enrollment, comprehensive focus on quality for reliable, audit-ready data, and the recruitment of 85% of participants from underrepresented groups. While each of their eight sites is affiliated with a local hospital, ACN's centralized management standardizes processes and technology, ensuring efficiency, quality, and consistent study execution across all sites. Their approach not only maximizes efficiency but also provides a solid foundation for scalable operations to meet study needs. ACN's dedication to diversity and quality in clinical research positions it as a promising investment opportunity in the United States.
There is no investment information
No recent news or press coverage available for Alliance Clinical Network.